This clinical practice guideline, entitled “Exercise therapy in metabolic and bariatric surgery,” was developed to advise Iranian individuals with obesity regarding exercise before and after MBS. It is a joint product of the Sports Medicine Department and the Minimally Invasive Research Center at Iran University of Medical Sciences (IUMS).
After registration with the Office of Standardization and Development of Clinical Guidelines, a subsidiary of Iran’s Ministry of Health and Medical Education, a multidisciplinary team (MDT) was established. Specialists in sports medicine, metabolic and bariatric surgery, obesity medicine, nutrition, physical therapy, and epidemiology, with more than a decade of work experience in the field of obesity, were recruited as MDT members. They determined the scope and priorities, searched for resources, developed scenarios, analyzed the clinical benefits of the scenarios, managed consensus, and summarized the results. Execution of all stages of development was supervised by the team leader (P.N.), who had experience in developing five clinical guidelines and was certified by the Office of Standardization and Development of Clinical Guidelines, Iran’s Ministry of Health and Medical Education.
The objective was to collect evidence-based information to support clinical advice on the preventive and therapeutic effects of physical activity in patients who are candidates for MBS. Using a structured approach, issues pertinent to exercise for MBS were specified so that they could be communicated to patients with obesity and MDT members. The viewpoints and preferences of patients, as well as the experience of MDT members, were also incorporated. The key topics addressed the practical needs of patients and clinicians.
A comprehensive systematic search on exercise and bariatric surgery was conducted in the following databases, regardless of study design, comparator groups, outcomes, language, and context: PubMed (MEDLINE), Scopus, Web of Science, The Canadian Practice Guidelines InfoBase, Agency for Healthcare Research and Quality (AHRQ), National Institute for Health and Care Excellence (NICE: www.nice.org.uk), Scottish Intercollegiate Guidelines Network (SIGN: www.sign.ac.uk), New Zealand Guidelines Group (www.health.govt.nz/publications), and the National Health and Medical Research Council (NHMRC: www.nhmrc.gov.au). The search key terms were obesity, metabolic and bariatric surgery, exercise, physical activity, consensus, and clinical practice guideline. No specific guidelines on exercise therapy for patients who are candidates for MBS were identified. Some clinical guidelines related to obesity management were available, in which exercise therapy and physical activity were mentioned briefly as part of lifestyle therapy for weight loss (Appendix 1 in the Supplementary File). Therefore, to specifically cite evidence regarding physical activity in MBS, we relied on systematic reviews and clinical trials, and on expert opinion when evidence was insufficient. Included studies were peer-reviewed English publications (from January 2000 to June 2024) addressing exercise interventions in pre- and post-MBS contexts. Case reports, editorials, and non-clinical papers were excluded.
A questionnaire comprising 16 clinical scenarios/questions was developed. The clinical questions concerned the efficacy, cost-benefit, and feasibility of exercise, as well as the details of an exercise protocol (Appendix 2 in the Supplementary File). Gaps between knowledge and practice, as well as the clinical need for developing guidance, were considered in the clinical scenarios. The PICO framework was used to formulate the 16 clinical questions to guide the evidence search and develop the practice approach. In this framework, P stands for Population (adults undergoing metabolic or bariatric surgery in this study); I for Intervention (structured pre- and postoperative exercise therapy in this study); C for Comparisons (if appropriate); and O for Outcome(s) (weight or fat loss, improved recovery, physical function, or quality of life in this study).
To determine how current evidence supports the clinical questions, a broad search of resources was conducted. The existing answers to the questions, as well as the scientific evidence supporting each answer, were presented as recommendations by the MDT members.
The overall quality of evidence supporting each proposed recommendation was determined. The clinical relevance and applicability of the recommendations were also assessed. In addition, the advantages and disadvantages of acting on each recommendation were evaluated.
The recommendations were voted on using a three-round Delphi technique to gather a broad range of ideas, opinions, and evidence from experts. Additional considerations included effectiveness, safety, cost, feasibility, patients’ buy-in, affordability, accessibility, and alternative scenarios. To evaluate recommendations, supporting evidence, and expected clinical benefits, standardized forms developed by the Office of Clinical Guideline Standardization were used. Clinical scenarios were assessed based on the existing literature, considering treatment effectiveness, benefits, side effects, costs, and applicability. The localizability of the guidance, including feasibility, generalizability, and acceptance, was also evaluated. Examples of the forms are provided in Appendix 3 in the Supplementary File.
All panel members scored each item in the form from 1 to 3, with higher scores indicating greater suitability of each scenario. In addition, agreement among experts was calculated, with higher agreement (> 90%) indicating a higher degree of certainty. Items with lower agreement scores were submitted to the next Delphi round of the expert panel. Scenarios with higher scores were ultimately selected and published as the best. Finally, the wording and priority of each recommendation were agreed upon by the expert panel.
During the drafting and final editing stages of the guidance, the AGREE (Appraisal of Guidelines for Research and Evaluation) Reporting Checklist was used to ensure the document is evidence-based, clear, and implementable (
18,
19). The purpose, applicability, clarity, and development process were assessed using the AGREE checklist.
This approach includes statements to assist practitioners in making decisions about appropriate physical activity for individuals with obesity. It can be applied to any candidate for MBS of any age, any gender, or with any associated medical problems. Different parts of this guideline would be suitable for use by policymakers; sports medicine specialists; obesity medicine specialists; metabolic and bariatric surgeons; general practitioners; dietitians; patients with obesity and their families; and administrators of obesity clinics. The guidance is accessible through the Office of Standardization and Development of Clinical Guidelines, the Ministry of Health and Medical Education of Iran (https://hetas.behdasht.gov.ir/). Moreover, it will be available through national obesity clinics for specialists and patients, and at all universities of medical sciences across the country. Feedback from the MDT and patients with obesity will be recorded to evaluate facilitators of and barriers to implementing this guidance.
This guidance is expected to be updated in 5 - 10 years.
The strength of evidence was determined according to the level and quality of evidence and statistical precision (
20). Levels of evidence are as follows:
Level 1A: Evidence from systematic reviews or meta-analyses of randomized controlled trials (RCTs); Level 1B: Evidence from at least one RCT Level 2A: Evidence from at least one controlled study without randomization; Level 2 B: Evidence from at least one other type of quasi-experimental study; Level 3: Evidence from non-experimental descriptive studies, such as comparative studies, correlation studies, and case-control studies; Level 4: Evidence from expert committee reports or opinions or clinical experience of respected authorities, or both
The scientific strength of the recommendations is as follows:
Grade A: Based on level 1 evidence (1A, 1B); Grade B: Based on level 2 evidence; Grade C: Based on level 3 evidence; Grade D: Based on level 4 evidence
- Metabolic and bariatric surgery refers to various surgical procedures aimed at aiding weight loss and improving associated medical problems in individuals with severe obesity, usually when other weight loss methods have failed. The ICD-11 (International Classification of Diseases; 11th revision) code for bariatric surgery is Z98.84.
- Exercise therapy is a therapeutic approach that uses physical activity to improve health, manage chronic conditions, and accelerate recovery from injuries. In the ICD-11 system, the relevant code for exercise counseling as a factor influencing the state of health is Z71.82.